(Allergan plc)

	AGN latest price $160.7875 (-0.28%) ($160.4649 - $162.6991) on Tue. Dec. 26, 2017.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.74% (three month average)
RSI	53
Latest Price	$160.7875(-0.28%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.8% a day on average for past five trading days.
Weekly Trend	AGN declines -0.5% a week on average for past two weeks.
Market Behavior	Growth stock sell-off for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(52%)    XLV(50%)    XBI(47%)    ARKG(46%)    SPY(46%)
Factors Impacting AGN price	AGN will decline at least -0.87% in a week (0% probabilities).   VIXM(-31%)    TLT(-19%)    UUP(-18%)    GDXJ(-5%)    SHY(-4%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.87% (StdDev 1.74%)
Hourly BBV	0 ()
Intraday Trend	-0.1%

Resistance Level	$165.3
5 Day Moving Average	$162.75(-1.21%)
10 Day Moving Average	$164.8(-2.43%)
20 Day Moving Average	$165.3(-2.73%)
To recent high	-21.7%
To recent low	0.1%
Market Cap	$53.012b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed